Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

Vaccine
Shahida BaqarO Pavlovskis

Abstract

The safety and immunogenicity of two prototype oral Campylobacter killed whole-cell (CWC) vaccines were tested in rhesus monkeys. Animals were immunized with a primary two-dose series (days 0 and 14) of vaccine consisting of CWC (10(10) particles/dose) given alone or in combination with 0.5-1000 micrograms of the heat-labile enterotoxin of Escherichia coli as an oral adjuvant (OA). A booster vaccination, 4 weeks after primary immunization, was given to animals receiving CWC alone or supplemented with 0.5, 5 or 50 micrograms of OA. Both CWC and CWC-OA were well tolerated, with no adverse side-effects noted. Campylobacter-specific as well as adjuvant-specific antibody-secreting cells (ASCs) were determined in peripheral blood collected 7 days after each vaccine dose. Campylobacter-specific IgA ASC responses were enhanced by OA in a dose-dependent manner (p = 0.025), while IgG ASC responses were not. Seroconversions (both IgA and IgG) to Campylobacter antigens were also enhanced in monkeys receiving adjuvanted vaccine. No significant booster vaccination effect was observed in circulating ASCs in any of the immunization groups. In vitro T-cell proliferative responses to Campylobacter jejuni antigens were somewhat enhanced in both t...Continue Reading

References

Nov 1, 1991·Immunology Today·A M Mowat, A M Donachie
Mar 1, 1988·The Journal of Infectious Diseases·R E BlackM J Blaser

❮ Previous
Next ❯

Citations

Sep 1, 1996·Digestive Diseases and Sciences·C T StadtländerT P Monath
Aug 23, 2001·Advanced Drug Delivery Reviews·R Glueck
Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S BaqarJ R Murphy
Aug 20, 2002·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Reinhard Glück
Dec 17, 2004·Journal of Clinical Gastroenterology·Brian CusterKris V Kowdley
Oct 25, 2000·Journal of Pediatric Gastroenterology and Nutrition·M M Levine
Jul 19, 2006·Clinical Microbiology Reviews·David J Diemert
Jul 16, 2008·Clinical Microbiology Reviews·Riny JanssenRobert J Owen
Nov 28, 2012·Infection and Immunity·Thomas W CullenM Stephen Trent
Dec 22, 2005·Infection and Immunity·Franca R JonesStephen E Walz
Nov 13, 2008·PloS One·Thomas F WierzbaRobert R Frenck
Nov 6, 2008·World Journal of Gastroenterology : WJG·Lian-Feng DuWan-Bang Sun
Jul 30, 2008·International Journal of Pharmaceutics·Surya K Mallapragada, Balaji Narasimhan
Dec 14, 2011·Expert Review of Vaccines·Abbas MuhammadPavol Kudela
Apr 29, 2009·Expert Review of Vaccines·Elzbieta Katarzyna Jagusztyn-KrynickaAgnieszka Wyszyńska
Jul 5, 2005·Expert Opinion on Investigational Drugs·C R Kensil, R Kammer
Jun 12, 2009·Critical Reviews in Microbiology·Arie H HavelaarDiane G Newell
Sep 27, 2018·Human Vaccines & Immunotherapeutics·Frédéric PolyChad K Porter
Oct 11, 2008·Clinical and Vaccine Immunology : CVI·C K PorterJ W Sanders
Jun 20, 2020·Gut Microbes·Hyesuk SeoWeiping Zhang
May 1, 1997·Clinical and Diagnostic Laboratory Immunology·S BaqarJ R Murphy
Aug 26, 1998·Infection and Immunity·A DuboisT Monath

❮ Previous
Next ❯

Related Concepts

Related Feeds

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.